Most cancers result from accumulation of multiple genetic alterations that lead to dysfunction of cancer-associated genes. These genetic alterations are important diagnostic, prognostic, and predictive biologic markers. Next generation sequencing technologies permit deep sequencing of hundreds of cancer genes concurrently.
Our Solid Tumor NGS Panel analyzes a set of key cancer gene mutations including many clinically actionable mutations. The test can provide important individual information regarding tumor development and progression, and a more reliable prediction of personalized cancer therapies.
Our caner panel tests are enhanced by the addition of analysis for gene copy number variations and fusions.
Our reports provide a detailed look at a patient's tumor including pathologic interpretation, prognostic features and therapeutic indications. Request a sample report now to see how our Solid Tumor NGS test can provide the oncology answers you're looking for.Request a Sample Report